跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,066 条关于
“SCA”
全部
16,066
临床试验
7,116
药物
584
机构
528
资讯
7,838
去年
NLX-112 Receives Orphan Drug Designation in Europe for Spinocerebellar Ataxia
去年
FDA Grants Priority Review to Troriluzole for Spinocerebellar Ataxia Treatment
去年
Biohaven's Troriluzole Shows Promise in Slowing Spinocerebellar Ataxia Progression
10个月前
FDA Issues Complete Response Letter for Biohaven's VYGLXIA (troriluzole) for Spinocerebellar Ataxia
去年
Allo-SCT Demonstrates Long-Term Superiority Over Standard Care in Sickle Cell Anemia
去年
Biohaven Secures $600 Million Non-Dilutive Funding from Oberland Capital for Rare Disease Drug Development
去年
Biohaven Withdraws EU Application for Troriluzole in Spinocerebellar Ataxia, RBC Remains Optimistic
去年
Biohaven Announces Third Quarter 2024 Financial Results and Business Developments
去年
Biohaven's Pipeline Advances Drive Optimistic Outlook for 2025
去年
L-Arginine Shows Promise but Falls Short of Statistical Significance in Spinocerebellar Ataxia Type 6 Trial
第 1 页,共 784 页
上一页
下一页